Quote:Interesting quote...
Quote:If leronlimab gains approval for treating triple-negative breast cancer, Hoffman said the company aims to partner with another pharmaceutical company to market it to patients.
After the initial BLA submission the FDA requires a marketing plan they can review to determine whether the drug can be distributed in an effective and safe manner. Unless Cytodyn can come up with the money for self-distribution and marketing we will need a partner. There is no way we'll set up an awful deal like the one we had with Shkreli's company.